Harakeh Steve, Khan Imran, Almasaudi Saad B, Azhar Esam I, Al-Jaouni Soad, Niedzweicki Aleksandra
Special Infectious Agents Unit, King Fahd Medical Research Center (KFMRC), King Abdulaziz University (KAU), Jeddah. Saudi Arabia.
Department of Biochemistry, Faculty of Science, KAU. Saudi Arabia.
Curr Drug Metab. 2017;18(9):858-867. doi: 10.2174/1389200218666170719095344.
Antimicrobial resistance is quickly spreading and has become a major public health problem worldwide. If this issue is not resolved, it may cause a shift back to the pre-antibiotics era and infectious disease will again be a serious problem, especially in developing countries. Since the discovery of antibiotics, bacterial resistance has emerged, enabling certain bacteria to withstand antibiotic action. The emergence of antibiotic resistance is fueled by excessive and improper use of antimicrobial agents, especially in developing countries. For this reason, alternatives to or modifications of current treatment methods have been sought. The aim of this review is to highlight the possible synergies of various agents that can augment antibiotic activities.
A structured literature search was conducted using only papers that have been published in PubMed with the focus on the agents that are likely to modulate antimicrobial resistance. In this review, data was retrieved from the literature regarding the possible synergies that exist between commercially available antimicrobial drugs with agents of interest. The papers included were summarized and analyzed, critiqued and compared for their contents using a conceptual frame-work.
In total, one hundred and twenty six papers were reviewed. The number of papers that dealt with the different topics included are as follows (): emergence of antimicrobial resistance (22), bioactive phyto-compounds (36) (phytobiologics, and phytochemicals), Antioxidants (40) (N-acetylcysteine, Ambroxol, Ascorbic acid, Glutathione and vitamin E), Peptide synergies (14) (Synthetic cationic α-helical AMPs, CopA3, Alafosfalin, PMAP-36, Phosphonopeptide L-norvalyl-L-1-aminoethylphosphonic acid and norcardicin-A), nano-antibiotics (10), drug-compound interactions (4).This review addressed the new strategies using the above compounds in the modulation of antimicrobial resistance to avoid issues related to resistance of bacteria to antibiotics.
The findings of this review confirm that certain compounds can act in synergy with currently used antimicrobials to enhance the potential of antimicrobial agents and thus to reduce the emergence of antimicrobial resistance. Some of these synergies are already being used to enhance the potential of currently used antimicrobial agents. More studies need to be conducted to better understand the mechanism of action of such compounds, and based on the results, new compounds may be sought.
抗菌药物耐药性正在迅速蔓延,已成为全球主要的公共卫生问题。如果这个问题得不到解决,可能会导致回到抗生素出现之前的时代,传染病将再次成为严重问题,尤其是在发展中国家。自从发现抗生素以来,细菌耐药性就已出现,使某些细菌能够抵抗抗生素的作用。抗菌药物的过度和不当使用加剧了抗生素耐药性的出现,特别是在发展中国家。因此,人们一直在寻找现有治疗方法的替代方案或改进方法。本综述的目的是强调各种能够增强抗生素活性的药物之间可能存在的协同作用。
进行了结构化文献检索,仅使用在PubMed上发表的论文,重点关注可能调节抗菌药物耐药性的药物。在本综述中,从文献中检索了关于市售抗菌药物与相关药物之间可能存在的协同作用的数据。对纳入的论文进行总结和分析,使用概念框架对其内容进行批判和比较。
总共审查了126篇论文。涉及不同主题的论文数量如下:抗菌药物耐药性的出现(22篇)、生物活性植物化合物(36篇)(植物生物制剂和植物化学物质)、抗氧化剂(40篇)(N-乙酰半胱氨酸、氨溴索、抗坏血酸、谷胱甘肽和维生素E)、肽协同作用(14篇)(合成阳离子α-螺旋抗菌肽、CopA3、阿拉磷、PMAP-36、膦肽L-正缬氨酰-L-1-氨基乙基膦酸和诺卡菌素-A)、纳米抗生素(10篇)、药物-化合物相互作用(4篇)。本综述探讨了使用上述化合物调节抗菌药物耐药性的新策略,以避免与细菌对抗生素耐药性相关的问题。
本综述的结果证实,某些化合物可以与目前使用的抗菌药物协同作用,增强抗菌药物的潜力,从而减少抗菌药物耐药性的出现。其中一些协同作用已经用于增强目前使用的抗菌药物的潜力。需要进行更多研究以更好地了解此类化合物的作用机制,并根据结果寻找新的化合物。